Cover Image
市場調查報告書

生物學心臟瓣膜的全球市場:2016∼2020年

Global Tissue Heart Valves Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 353214
出版日期 內容資訊 英文 41 Pages
訂單完成後即時交付
價格
Back to Top
生物學心臟瓣膜的全球市場:2016∼2020年 Global Tissue Heart Valves Market 2016-2020
出版日期: 2016年02月24日 內容資訊: 英文 41 Pages
簡介

心臟瓣膜有機械瓣膜和生物學心臟瓣膜。生物學心臟瓣膜採用牛豬,人的組織等各種東西。與機械瓣膜比,生物學心臟瓣膜跨一生使用抗凝血劑。全球醫療設施,每年進行30萬件心臟瓣膜置換手術。全球生物學心臟瓣膜市場,預計2016∼2020年以年複合成長率3.81%擴大。

本報告提供全球生物學心臟瓣膜市場現狀與今後的成長預測,各地區趨勢,以及市場趨勢與課題,主要供應商簡介等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

  • 市場焦點

第5章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 成本分析

  • 瓣膜置換術的成本分析

第7章 各產品市場區隔

第8章 各地區市場區隔

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第9章 推動市場的要素

  • 心臟瓣膜疾病的罹患率
  • 支架無生物學心臟瓣膜的需求
  • 微創手術的引進
  • 高齡化

第10章 促進要素的影響

第11章 市場課題

  • 替代產品的規格
  • 潛在的併發症風險
  • 熟練人員的不足
  • 嚴格的相關法規

第12章 促進要素及課題的影響

第13章 市場趨勢

  • 亞太地區生物學心臟瓣膜的需求
  • 高齡人口
  • M&A的增加

第14章 供應商環境

  • 競爭模式
  • 市場佔有率:2015年
  • Edwards Lifesciences
  • LivaNova
  • Medtronic
  • St. Jude Medical
  • 其他值得注意的供應商

第15章 附錄

第16章 關於Technavio

圖表

目錄
Product Code: IRTNTR8800

About Tissue Heart Valves

Heart valves are prosthetic cardiovascular medical devices that are used to replace a defective heart valve. These valves can be biological (tissue) or mechanical. Manufacturers develop tissue heart valves from various sources such as bovine, porcine, and human tissues. Devices developed using human tissues are known as allografts or homografts. The implantation of these devices does not require the lifelong use of blood-thinner medications compared to mechanical tissue heart valves. They also ensure unidirectional flow of the blood across heart chambers. The medical facilities worldwide perform about 300,000 heart valve replacement procedures each year.

Technavio's analysts forecast the global tissue heart valves market to grow at a CAGR of 3.81% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global tissue heart valves market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of tissue heart valve implants.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Tissue Heart Valves Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Edwards Lifesciences
  • LivaNova
  • Medtronic
  • St. Jude Medical

Other Prominent Vendors

  • Braile Biomedica
  • CryoLife
  • Labcor Laboratorios

Market driver

  • Demand for stentless tissue valves
  • For a full, detailed list, view our report

Market challenge

  • Lack of skilled personnel
  • For a full, detailed list, view our report

Market trend

  • Increase in M&A
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Cost analysis

  • Cost analysis of valve replacement procedures

PART 07: Market segmentation by product

PART 08: Geographical segmentation

  • Tissue heart valves market in Americas
  • Tissue heart valves market in EMEA
  • Tissue heart valves market in APAC

PART 09: Market drivers

  • Prevalence of heart valve diseases
  • Demand for stentless tissue valves
  • Implementation of MI procedures
  • Rise in geriatric population

PART 10: Impact of drivers

PART 11: Market challenges

  • Use of alternative products
  • Risk of potential complications
  • Lack of skilled personnel
  • Stringent regulatory framework

PART 12: Impact of drivers and challenges

PART 13: Market trends

  • Demand for tissue heart valves in APAC
  • Preference among geriatric population
  • Increase in M&A

PART 14: Vendor landscape

  • Competitive scenario
  • Market share analysis 2015
  • Edwards Lifesciences
  • LivaNova
  • Medtronic
  • St. Jude Medical
  • Other prominent vendors

PART 15: Appendix

  • List of abbreviations

PART 16: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Global tissue heart valves market 2015-2020 ($ billions)
  • Exhibit 03: Five forces analysis
  • Exhibit 04: Cost comparison of heart valve replacement procedures (high-risk group)
  • Exhibit 05: Global tissue heart valves market segmentation by product
  • Exhibit 06: Global tissue heart valves market segmentation by product 2015
  • Exhibit 07: Global tissue heart valves market segmentation by geography 2015
  • Exhibit 08: Global tissue heart valves market segmentation by geography 2020
  • Exhibit 09: Global tissue heart valves market segmentation by geography 2015-2020
  • Exhibit 10: Tissue heart valves market in Americas 2015-2020 ($ millions)
  • Exhibit 11: Tissue heart valves market in US 2015-2020 ($ millions)
  • Exhibit 12: Tissue heart valves market in EMEA 2015-2020 ($ millions)
  • Exhibit 13: Tissue heart valves market in APAC 2015-2020 ($ millions)
  • Exhibit 14: Impact of drivers
  • Exhibit 15: Impact of drivers and challenges
  • Exhibit 16: Cost comparison of heart valve replacement procedures
  • Exhibit 17: Ranking of top vendors 2015
  • Exhibit 18: Edwards Lifesciences: Key takeaways
  • Exhibit 19: LivaNova: Key takeaways
  • Exhibit 20: Medtronic: Key product offerings
  • Exhibit 21: Medtronic: Key takeaways
  • Exhibit 22: St. Jude Medical: Key takeaways
Back to Top